^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PSMA1 expression

    i
    Other names: PSMA1, Proteasome 20S Subunit Alpha 1, PROS30, HC2, NU, Proteasome (Prosome, Macropain) Subunit, Alpha Type, 1, Multicatalytic Endopeptidase Complex Subunit C2, Proteasome Subunit Alpha Type-1, Proteasome Subunit Alpha 1, 30 KDa Prosomal Protein, Proteasome Component C2, Macropain Subunit C2, Proteasome Nu Chain, PROS-30, Epididymis Secretory Protein Li 275, Proteasome Subunit, Alpha-Type, 1, Testicular Tissue Protein Li 150, Proteasome Subunit Alpha 6, Proteasome Subunit Α6, Proteasome Subunit Nu, Macropain Subunit Nu, Protein P30-33K, HEL-S-275, MGC14542, MGC14575, MGC14751, MGC21459, MGC22853, MGC23915, MGC1667, PSC2
    Entrez ID:
    5682
    Related biomarkers:
    Expression
    2ms
    LncRNA PSMA-AS1 affects glioma cell metastasis through mediating pyroptosis via miR-140-3p/SRSF10 axis. (PubMed, Cytotechnology)
    In addition, SRSF10 is a downstream binding target of miR-140-3p, and inhibition of SRSF10 also promoted pyroptosis and inhibited glioma cells proliferation and metastasis. In conclusion, our results confirmed that PSMA1-AS1 affects glioma cell proliferation and metastasis by regulating pyroptosis through miR-140-3p/SRSF10 axis, suggesting that LncRNA PSMA1-AS1 may be a potential target for glioma.
    Journal
    |
    PSMA1 (Proteasome 20S Subunit Alpha 1) • MIR140 (MicroRNA 140)
    |
    PSMA1 expression
    almost2years
    Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma. (PubMed, Odontology)
    PSMA1 upregulation in HNSCC association with adverse clinicopathological features and prognosis underscores its potential significance. Further research is warranted to elucidate its molecular mechanisms and therapeutic potential in OSCC management.
    Journal
    |
    PSMA1 (Proteasome 20S Subunit Alpha 1)
    |
    PSMA1 expression